IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq: ELGX), the developer and manufacturer of the Powerlink® System for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today announced that it has received notice of Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) and will soon be initiating Powerlink System product shipments to Japan.
